BlackRock Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $298K | Buy |
9,313
+1,339
| +17% | +$42.8K | ﹤0.01% | 2529 |
|
|
2016
Q3 | $399K | Buy |
7,974
+2,448
| +44% | +$122K | ﹤0.01% | 2371 |
|
|
2016
Q2 | $234K | Sell |
5,526
-67
| -1% | -$2.84K | ﹤0.01% | 2514 |
|
|
2016
Q1 | $369K | Buy |
5,593
+1,721
| +44% | +$114K | ﹤0.01% | 2342 |
|
|
2015
Q4 | $240K | Sell |
3,872
-1,896
| -33% | -$118K | ﹤0.01% | 2458 |
|
|
2015
Q3 | $386K | Buy |
5,768
+2,571
| +80% | +$172K | ﹤0.01% | 2285 |
|
|
2015
Q2 | $311K | Sell |
3,197
-1,959
| -38% | -$191K | ﹤0.01% | 2429 |
|
|
2015
Q1 | $482K | Sell |
5,156
-1,913
| -27% | -$179K | ﹤0.01% | 2207 |
|
|
2014
Q4 | $629K | Buy |
7,069
+6,439
| +1,022% | +$573K | ﹤0.01% | 2137 |
|
|
2014
Q3 | $44K | Hold |
630
| – | – | ﹤0.01% | 2684 |
|
|
2014
Q2 | $37K | Buy |
630
+550
| +688% | +$32.3K | ﹤0.01% | 2703 |
|
|
2014
Q1 | $3K | Sell |
80
-560
| -88% | -$21K | ﹤0.01% | 2712 |
|
|
2013
Q4 | $27K | Hold |
640
| – | – | ﹤0.01% | 2576 |
|
|
2013
Q3 | $19K | Hold |
640
| – | – | ﹤0.01% | 2790 |
|
|
2013
Q2 | $34K | Buy |
+640
| New | +$34K | ﹤0.01% | 2480 |
|